avicorelogo.png
Avricore Health’s HealthTab™ Passes 530 Locations, Adds Virus Detection
March 23, 2023 10:46 ET | Avricore Health Inc.
VANCOUVER, British Columbia, March 23, 2023 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) continues to grow the HealthTab™ network of pharmacy locations, reaching...
LOGO-01.png
Burning Rock Schedules Fourth Quarter and Full Year 2022 Earnings Release on March 28, 2023
March 07, 2023 03:38 ET | Burning Rock Biotech Limited
GUANGZHOU, China, March 07, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation...
Amydis_Logo_Horiz_RGB@2x.png
Amydis Announces Enrollment of Cerebral Amyloid Angiopathy Participants in Phase 1/2a Retinal Tracer Trial
February 21, 2023 05:00 ET | Amydis, Inc.
SAN DIEGO, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Amydis Inc., a privately held clinical-stage company pioneering a platform of ocular tracers that enable imaging of disease biomarkers in the eye, today...
LOGO-01.png
Burning Rock provides an update on 2022 revenue guidance
January 17, 2023 20:37 ET | Burning Rock Biotech Limited
GUANGZHOU, China, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation...
LOGO-01.png
Burning Rock Received FDA Breakthrough Device Designation for its OverC™ Multi-Cancer Detection Blood Test
January 03, 2023 09:25 ET | Burning Rock Biotech Limited
IRVINE, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Burning Rock (NASDAQ/LSE: BNR), a company focused on the application of next generation sequencing (NGS) technology in the field of precision...
LOGO-01.png
Burning Rock Reports Third Quarter 2022 Financial Results
November 15, 2022 21:20 ET | Burning Rock Biotech Limited
GUANGZHOU, China, Nov. 15, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation...
Amydis_Logo_Horiz_RGB@2x.png
Amydis Awarded Third Grant From The Michael J. Fox Foundation To Support First-In-Human Study of a Retinal Tracer for Parkinson’s Disease
October 27, 2022 07:00 ET | Amydis, Inc.
SAN DIEGO, Oct. 27, 2022 (GLOBE NEWSWIRE) -- Amydis Inc., a privately held clinical-stage company pioneering a platform of diagnostic drug candidates targeting molecular biomarkers in the eye, today...
LOGO-01.png
Burning Rock Reports Second Quarter 2022 Financial Results
August 31, 2022 05:29 ET | Burning Rock Biotech Limited
GUANGZHOU, China, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
avicorelogo.png
Avricore Health Reports Second-Quarter 2022 Results
August 29, 2022 08:30 ET | Avricore Health Inc.
VANCOUVER, British Columbia, Aug. 29, 2022 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is pleased to provide this corporate update on the Company’s Q2 results. ...
Fountain Life Selected as Official Preventative Healthcare Provider for Invited
Fountain Life Selected as Official Preventative Healthcare Provider for Invited, Formerly ClubCorp, Expanding Mission to Enhance Longevity and Performance
July 20, 2022 09:00 ET | Fountain Life
NAPLES, Fla., July 20, 2022 (GLOBE NEWSWIRE) -- Fountain Life, a preventative medicine company committed to transforming global healthcare from reactive to proactive, is excited to announce its...